Solving the complexities of brain cancer diagnostics
NYU Langone Director of Molecular Pathology Matija Snuderl says every brain cancer journey should begin with DNA methylation profiling
NYU Langone Director of Molecular Pathology Matija Snuderl says every brain cancer journey should begin with DNA methylation profiling
At the San Diego headquarters, participants took a break from work to connect and create art
Illumina UK and Ireland commercial lead James Clarke goes the distance for dementia patients
The Illumina Genomics Summit highlighted the role of strategic collaborations to improve health outcomes in the country
Think you know the ins and outs of an instrument? Illumina’s Sireesha Lujan studies every step—so you don’t have to
Date | Publication | Title |
---|---|---|
May 14, 2025 | BioSpectrum | Illumina unveils DRAGEN version 4.4 software focusing on oncology applications for clinical research |
May 6, 2025 | Bio-IT World | Illumina, Ovation Release GLP-1 Patient Dataset |
May 1, 2025 | GenomeWeb | Illumina, Ovation.io Partner on Multiomics Analysis of Patients Treated With GLP-1 Therapies |
Apr 30, 2025 | Bio Spectrum | Govt initiatives and private sector investments are boosting adoption of NGS technologies for various applications |
Apr 25, 2025 | Inside Precision Medicine | Childhood cancer treatment transformed by Ireland’s MAGIC-I study |
At Illumina, we push boundaries. We think beyond the conventional. We dream big. With the energy of so many bright and accomplished people, the opportunities are endless.
Search for JobsIf you are a member of the media:
If you are not a member of the media, please visit Contact Us.